Femme et Homme
- | Pays :
- United States
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to determine the safety, tolerability, and pharmacokinetics of 14 days of treatment with PF-05180999 in healthy subjects.
Critère d'inclusion
- Schizophrenia